Nociception Level Index Monitoring During Cesarean Section
NCT: NCT07720440 · COMPLETED
Brief Summary
This prospective randomized controlled trial evaluated the effect of nociception level (NOL) index-guided intraoperative analgesia on postoperative pain management in patients undergoing elective cesarean section under general anesthesia. Sixty patients were randomly assigned to either NOL-guided analgesia or standard intraoperative monitoring. The primary outcome was postoperative pain intensity assessed using the visual analog scale (VAS) during the first 24 hours after surgery. Secondary outcomes included postoperative opioid requirements and time to first breastfeeding. The study aimed to determine whether objective intraoperative nociception monitoring could improve postoperative analgesia and enhance early maternal recovery.
Frequently Asked Questions
What is Nociception Level Index Monitoring During Cesarean Section?
Nociception Level Index Monitoring During Cesarean Section is a clinical trial registered under NCT07720440. Current status: COMPLETED.
What is the status of NCT07720440?
The current status of NCT07720440 (Nociception Level Index Monitoring During Cesarean Section) is: COMPLETED.
When did Nociception Level Index Monitoring During Cesarean Section start?
Nociception Level Index Monitoring During Cesarean Section started on 2023-08-15.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.